This book is organized into 4 sections, each looking at the question of outcome prediction in cancer from a different angle. The first section describes the clinical problem and some of the predicaments that clinicians face in dealing with cancer. Amongst issues discussed in this section are the TNM staging, accepted methods for survival analysis and competing risks. The second section describes the biological and genetic markers and the rôle of bioinformatics. Understanding of the genetic and environmental basis of cancers will help in identifying high-risk populations and developing…mehr
This book is organized into 4 sections, each looking at the question of outcome prediction in cancer from a different angle. The first section describes the clinical problem and some of the predicaments that clinicians face in dealing with cancer. Amongst issues discussed in this section are the TNM staging, accepted methods for survival analysis and competing risks. The second section describes the biological and genetic markers and the rôle of bioinformatics. Understanding of the genetic and environmental basis of cancers will help in identifying high-risk populations and developing effective prevention and early detection strategies. The third section provides technical details of mathematical analysis behind survival prediction backed up by examples from various types of cancers. The fourth section describes a number of machine learning methods which have been applied to decision support in cancer. The final section describes how information is shared within the scientific and medical communities and with the general population using information technology and the World Wide Web.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Artikelnr. des Verlages: B978-0-444-52855-1.X5000-4
Seitenzahl: 482
Erscheinungstermin: 1. Januar 2007
Englisch
Abmessung: 246mm x 189mm x 26mm
Gewicht: 1010g
ISBN-13: 9780444528551
ISBN-10: 0444528555
Artikelnr.: 21550868
Autorenporträt
Azzam Taktak is a Principal Clinical Scientist in the Department of Clinical Engineering, Royal Liverpool University Hospital and an Honorary Lecturer at the University of Liverpool. His main research interests are the application of mathematical models and artificial intelligence to medical applications specifically in cancer.
Anthony Fisher is a Consultant Clinical Scientist in the Department of Clinical Engineering, Royal Liverpool University Hospital. Previously he was a Senior Lecturer in Bioengineering at the University of Strathclyde. Glasgow. His principal academic interests are biomedical instrumentation and signal processing.
Inhaltsangabe
Section 1 - The Clinical Problem.
THE PREDICTIVE VALUE OF DETAILED HISTOLOGICAL STAGING OF SURGICAL RESECTION SPECIMENS IN ORAL CANCER
Chapter 1: The predictive value of detailed histological staging of surgical resection specimens in oral cancer. J. Woolgar Liverpool Dental School, UK
Chapter 2: Survival after Treatment of Intraocular Melanoma. B.E. Damato, A.F.G. Taktak, Royal Liverpool University Hospital, UK
Chapter 3: Recent developments in relative survival analysis. T. Hakulinen, T.A. Dyba, Finnish Cancer Registry
Section 2 - Biological and Genetic Factors
Chapter 4: Environmental and genetic risk factors of lung cancer. A. Cassidy, J.K. Field, University of Liverpool, UK
Chapter 5: Chaos, cancer, the cellular operating system and the prediction of survival in head and neck cancer. A.S. Jones, University Hospital Aintree, UK
Section 3 - Mathematical Background of Prognostic Models
Chapter 6: Flexible hazard modelling for outcome prediction in cancer - perspectives for the use of bioinformatics knowledge. E.Biganzoli1, P. Boracchi2 1 Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy 2 Università degli Studi di Milano, Milano, Italy
Chapter 7: Information geometry for survival analysis and feature selection by neural networks. A. Eleuteri 1,2, R. Tagliaferri 3,4, L. Milano 1,2, M. De Laurentiis 1 1Università di Napoli, Italy 2INFN sez. Napoli, Italy 3Universit`a di Salerno, Italy 4INFN sez. distaccata di Salerno, Italy
Chapter 8: Artificial neural networks used in the survival analysis of breast cancer patients: A node negative study. C.T.C. Arsene, P.J. Lisboa, Liverpool John Moores University, UK
Section 4 - Application of Machine Learning Methods
Chapter 9: The use of artificial neural networks for the diagnosis and estimation of prognosis in cancer patients. A. Marchevsky, Cedars-Sinai Medical Center, Los Angeles, USA
Chapter 10: Machine learning contribution to solve prognosis medical problems. F. Baronti, A. Micheli, A. Passaro, A.Starita, University of Pisa, Italy
Chapter 11: Classification of brain tumours by pattern recognition of Magnetic Resonance Imaging and Spectroscopic data. A. Devos1, S. Van Huffel1 A.W. Simonetti1, M. van der Graaf2, A. Heerschap2, L.M.C. Buydens3 1Katholieke Universiteit Leuven, Belgium 2University Nijmegen Medical Centre, The Netherlands 3Radboud University Nijmegen, The Netherlands
Chapter 12: Towards automatic risk analysis for hereditary non-polyposis colorectal cancer based on pedigree data. M. Kokuer1, R.N.G. Naguib1, P. Jancovic2, H.B. Younghusband3, R. Green3 1Coventry University, UK 2University of Birmingham, UK 3University of Newfoundland, Canada
Chapter 13: The impact of microarray technology in brain cancer. M. Kounelakis1, M. Zervakis1, X. Kotsiakis2 1Technical University of Crete, GREECE 2District Hospital of Chania, GREECE
Section 5 - Dissemination of Information
Chapter 14: The web and the new generation of medical information. J.M. Fonseca, A.D. Mora, P. Barroso University of Lisbon, Portugal
Chapter 15: Geoconda: a web environment for multi-centre research. C. Setzkorn, A.F.G. Taktak, B.E. Damato Royal Liverpool University Hospital, Liverpool, UK
Chapter 16: The development and execution of medical prediction models. M.W. Kattan1, M. Gönen2, P.T. Scardino2 1The Cleveland Clinic Fondation, Cleveland, USA 2Memorial Sloan-Kettering Cancer Center, New York, USA
THE PREDICTIVE VALUE OF DETAILED HISTOLOGICAL STAGING OF SURGICAL RESECTION SPECIMENS IN ORAL CANCER
Chapter 1: The predictive value of detailed histological staging of surgical resection specimens in oral cancer. J. Woolgar Liverpool Dental School, UK
Chapter 2: Survival after Treatment of Intraocular Melanoma. B.E. Damato, A.F.G. Taktak, Royal Liverpool University Hospital, UK
Chapter 3: Recent developments in relative survival analysis. T. Hakulinen, T.A. Dyba, Finnish Cancer Registry
Section 2 - Biological and Genetic Factors
Chapter 4: Environmental and genetic risk factors of lung cancer. A. Cassidy, J.K. Field, University of Liverpool, UK
Chapter 5: Chaos, cancer, the cellular operating system and the prediction of survival in head and neck cancer. A.S. Jones, University Hospital Aintree, UK
Section 3 - Mathematical Background of Prognostic Models
Chapter 6: Flexible hazard modelling for outcome prediction in cancer - perspectives for the use of bioinformatics knowledge. E.Biganzoli1, P. Boracchi2 1 Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy 2 Università degli Studi di Milano, Milano, Italy
Chapter 7: Information geometry for survival analysis and feature selection by neural networks. A. Eleuteri 1,2, R. Tagliaferri 3,4, L. Milano 1,2, M. De Laurentiis 1 1Università di Napoli, Italy 2INFN sez. Napoli, Italy 3Universit`a di Salerno, Italy 4INFN sez. distaccata di Salerno, Italy
Chapter 8: Artificial neural networks used in the survival analysis of breast cancer patients: A node negative study. C.T.C. Arsene, P.J. Lisboa, Liverpool John Moores University, UK
Section 4 - Application of Machine Learning Methods
Chapter 9: The use of artificial neural networks for the diagnosis and estimation of prognosis in cancer patients. A. Marchevsky, Cedars-Sinai Medical Center, Los Angeles, USA
Chapter 10: Machine learning contribution to solve prognosis medical problems. F. Baronti, A. Micheli, A. Passaro, A.Starita, University of Pisa, Italy
Chapter 11: Classification of brain tumours by pattern recognition of Magnetic Resonance Imaging and Spectroscopic data. A. Devos1, S. Van Huffel1 A.W. Simonetti1, M. van der Graaf2, A. Heerschap2, L.M.C. Buydens3 1Katholieke Universiteit Leuven, Belgium 2University Nijmegen Medical Centre, The Netherlands 3Radboud University Nijmegen, The Netherlands
Chapter 12: Towards automatic risk analysis for hereditary non-polyposis colorectal cancer based on pedigree data. M. Kokuer1, R.N.G. Naguib1, P. Jancovic2, H.B. Younghusband3, R. Green3 1Coventry University, UK 2University of Birmingham, UK 3University of Newfoundland, Canada
Chapter 13: The impact of microarray technology in brain cancer. M. Kounelakis1, M. Zervakis1, X. Kotsiakis2 1Technical University of Crete, GREECE 2District Hospital of Chania, GREECE
Section 5 - Dissemination of Information
Chapter 14: The web and the new generation of medical information. J.M. Fonseca, A.D. Mora, P. Barroso University of Lisbon, Portugal
Chapter 15: Geoconda: a web environment for multi-centre research. C. Setzkorn, A.F.G. Taktak, B.E. Damato Royal Liverpool University Hospital, Liverpool, UK
Chapter 16: The development and execution of medical prediction models. M.W. Kattan1, M. Gönen2, P.T. Scardino2 1The Cleveland Clinic Fondation, Cleveland, USA 2Memorial Sloan-Kettering Cancer Center, New York, USA
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
